A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.

Preliminary data would suggest that the pineal hormone, melatonin (MLT), may enhance tamoxifen (TMX) anti-tumour efficacy. Both MLT and TMX have been used as single agents in the palliative treatment of metastatic neoplasms, other than the classical hormone-dependent tumours, without, however, any c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lissoni, P., Paolorossi, F., Tancini, G., Ardizzoia, A., Barni, S., Brivio, F., Maestroni, G. J., Chilelli, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074765/
https://www.ncbi.nlm.nih.gov/pubmed/8912546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074765/
https://www.ncbi.nlm.nih.gov/pubmed/8912546

Ejemplares similares